compounding pharmacy selling semaglutide Injection | Starts at $149/mo Compounded' weight-loss drugs are a

US Patent Nos

As intracerebral primary afferent neurons, MTNs respond sensitively to tooth contact and tension changes, dynamically regulating masticatory muscle activity and reflex gain (Giovanni and Giorgia, 2021)

A low-serum level of IGF-1 has been associated with insulin resistance, and [...] recombinant IGF-1 has been [hypothesized] to improve insulin sensitivity and glucose metabolism. Receptor Grade IGF-1 LR3 and Cell Lifespan Research (6) on murine models observed that common markers of physiological decline, such as muscle tears and neurological deficiencies, appeared to be mitigated for an extended period following routine exposure to the peptide

I suspect that comes as much from competition from newer generation GLP-1 agonists and similar meds from other companies than anything else